SCNI: Scinai Immunotherapeutics Company Short-Term Debt
This chart of Scinai Immunotherapeutics (SCNI) asset value demonstrates the 0.00 metric. Share price action remains independent of the broader economy, as business success is determined by the results of nanobody tests for gastrointestinal therapy. The model relies on the efficiency of the NanoAb system and the volume of antibody production in rodent cells. The company's innovations involve creating inhalable biologics based on llama antibodies to combat COVID and influenza.
Metric breakdowns and analytics for BiondVax Pharmaceuticals (SCNI)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Scinai Immunotherapeutics|SCNI - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Scinai Immunotherapeutics|SCNI - Company Total Debt|Debt to Book Capitalization Ratio Scinai Immunotherapeutics Ltd.|SCNI - Company Long-Term Liabilities|Company Current Liabilities Scinai Immunotherapeutics|Quick Liquidity scinai.com
- net income and valuation multiples indicators:
Initial company analysis:SCNI - Scinai Immunotherapeutics Ltd.
For Scinai Immunotherapeutics (SCNI), which is developing CDMO services and proprietary immunotherapy research, an analysis of short-term balance sheet liabilities allows for an assessment of the operating model's liquidity. This indicator aggregates all loans with a maturity of up to one year, measuring the issuer's ability to service urgent payments without compromising R&D, where a reduction in debt may either signal financial recovery or indicate investment stagnation.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|UPB - Company Short-Term Debt|Short-Term Debt Volume Zenas Corp ZBIO|IMNM: Company Short-Term Debts|Company Current Liabilities gossamerbio.com|KALV (KalVista Pharmaceuticals, Inc.) - Company Short-Term Debts|Septerna, Inc. (SEPN) - Short-Term Debt Volume|Company Short-Term Debt Pieris Pharmaceuticals Inc (PVLA)|Savara Pharma - Company Short-Term Indebtedness|Company Short-Term Debts RIGL (Rigel Pharmaceuticals)|Company Short-Term Debts anaptysbio.com ANAB|Astria Therapeutics, Inc. - Company Short-Term Debts|Short-Term Debt Volume enGene Holdings Inc ENGN|RAPT (RAPT Therapeutics) - Company Current Liabilities|Aerovate Therapeutics - Company Short-Term Loans and Borrowings|ACRS (Aclaris Therapeutics) - Company Short-Term Debts|kyvernatx.com (KYTX) - Short-Term Debt Volume|Company Short-Term Debt Tiziana Life Sciences Ltd (TLSA)|Company Current Liabilities Cabaletta Bio Inc. CABA|Company Short-Term Debt Ventyx Bio VTYX|THTX - Company Current Liabilities|AVTX: Company Current Liabilities|ELDN - Company Short-Term Debts|Agenus Inc. (AGEN) - Company Short-Term Debt|Company Short-Term Indebtedness CLYM|Company Short-Term Debt Zura Bio|Short-Term Debt aTyr Pharmaceuticals ATYR|Company Current Liabilities ADAG (Adagene)|Amount of Current Liabilities IMA|Company Short-Term Debts STTK (Shattuck Labs)|Company Short-Term Loans and Borrowings EQ|Connect Pharma - Company Short-Term Debts|Short-Term Debt Immunic, Inc.|atarabio.com (ATRA) - Company Short-Term Debt|InflaRx - Company Short-Term Loans and Borrowings|XFOR (X4 Pharmaceuticals, Inc.) - Company Short-Term Debts|Company Short-Term Debts Adicet|Company Short-Term Debt Celularity Inc. (CELU)|INMB: Current Liabilities|Company Short-Term Debts BRNS (Barinthus Biotherapeutics)|kezarlifesciences.com (KZR) - Short-Term Debt|SABS: Company Current Liabilities|AKTX - Company Short-Term Debts|ENLV (enlivex.com) - Company Current Liabilities|QTTB: Amount of Current Liabilities|GOVX (GeoVax Labs, Inc.) - Company Short-Term Debts|edesabiotech.com (EDSA) - Short-Term Debt Volume|Company Short-Term Debts IBIO|Company Current Liabilities carismatx.com CARM|Company Short-Term Debt XTL Biopharmaceuticals, Ltd. XTLB|Short-Term Debt Volume Bolt Biotherapeutics Inc. (BOLT)|HCWB - Company Short-Term Debt|Short-Term Debt Volume Aptevo Therapeutics APVO|AIM: Company Short-Term Debts|Company Current Liabilities Aditxt, Inc.|Company Short-Term Debt GRI Bio Corp|Company Short-Term Indebtedness XRTX (XORTX Corp)|Company Short-Term Debts HIND|Short-Term Debt Volume revbiosciences.com|Company Short-Term Debt Indaptus Therapeutics, Inc. INDP|CALI (CalciMedica Inc) - Current Liabilities|Affimed Therapeutics - Company Short-Term Debts|Company Short-Term Loans and Borrowings ALLK (Allakos Inc.)|HOOK: Company Short-Term Debts|IGM Biosciences (IGMS) - Company Short-Term Debts|Company Short-Term Debt iTeos Therapeutics, Inc.|OCEA: Company Short-Term Loans and Borrowings|Company Short-Term Debt TC BioPharm (Holdings) PLC (TCBP)|Company Current Liabilities Third Harmonic Bio Inc THRD